Equities

JiangSu WuZhong Pharmaceutical Development Co Ltd

600200:SHH

JiangSu WuZhong Pharmaceutical Development Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)8.34
  • Today's Change-0.13 / -1.53%
  • Shares traded9.25m
  • 1 Year change+8.59%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,6021,4931,261
Total Receivables, Net1,169942790
Total Inventory107113126
Prepaid expenses122718
Other current assets, total111154489
Total current assets3,0012,7302,684
Property, plant & equipment, net263232254
Goodwill, net------
Intangibles, net236204192
Long term investments796730621
Note receivable - long term3.243.02--
Other long term assets0.400.39--
Total assets4,3273,9103,758
LIABILITIES
Accounts payable276240132
Accrued expenses373138
Notes payable/short-term debt1,6171,3951,157
Current portion long-term debt/capital leases403363
Other current liabilities, total410157306
Total current liabilities2,3791,8561,696
Total long term debt141165168
Total debt1,7971,5931,388
Deferred income tax8.995.956.05
Minority interest172022
Other liabilities, total375912
Total liabilities2,5832,1061,903
SHAREHOLDERS EQUITY
Common stock712712712
Additional paid-in capital1,4121,4041,403
Retained earnings (accumulated deficit)(370)(298)(222)
Treasury stock - common(10)(15)(40)
Unrealized gain (loss)(0.24)0.171.62
Other equity, total------
Total equity1,7441,8041,855
Total liabilities & shareholders' equity4,3273,9103,758
Total common shares outstanding704705705
Treasury shares - common primary issue7.837.837.83
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.